Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$76.22 - $98.51 $990 - $1,280
-13 Reduced 7.98%
150 $14,000
Q2 2023

Jul 11, 2023

SELL
$86.68 - $100.3 $21,583 - $24,974
-249 Reduced 60.44%
163 $14,000
Q1 2023

Apr 21, 2023

SELL
$87.74 - $117.27 $15,442 - $20,639
-176 Reduced 29.93%
412 $40,000
Q4 2022

Jan 20, 2023

SELL
$80.93 - $108.63 $2,104 - $2,824
-26 Reduced 4.23%
588 $0
Q3 2022

Oct 17, 2022

BUY
$82.16 - $96.94 $38,122 - $44,980
464 Added 309.33%
614 $54,000
Q2 2022

Aug 03, 2022

BUY
$71.48 - $86.85 $10,722 - $13,027
150 New
150 $13,000
Q3 2020

Oct 19, 2020

SELL
$71.87 - $131.03 $1,868 - $3,406
-26 Closed
0 $0
Q2 2020

Jul 17, 2020

BUY
$79.55 - $124.22 $2,068 - $3,229
26 New
26 $3,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.